https://www.alphacognition.com/ 1.00 https://www.alphacognition.com/corporate/about-aci/ 0.80 https://www.alphacognition.com/corporate/team/ 0.80 https://www.alphacognition.com/our-approach/alzheimers-disease/ 0.80 https://www.alphacognition.com/our-approach/alpha-1062/ 0.80 https://www.alphacognition.com/our-approach/traumatic-brain-injury/ 0.80 https://www.alphacognition.com/our-approach/amyotrophic-lateral-sclerosis/ 0.80 https://www.alphacognition.com/our-approach/alpha-0602/ 0.80 https://www.alphacognition.com/our-approach/our-pipeline/ 0.80 https://www.alphacognition.com/investors/stock-info/ 0.80 https://www.alphacognition.com/investors/news/ 0.80 https://www.alphacognition.com/investors/presentations/ 0.80 https://www.alphacognition.com/investors/investor-relations-contact/ 0.80 https://www.alphacognition.com/contact/ 0.80 https://www.alphacognition.com/_resources/presentations/corporate-presentation.pdf 0.80 https://www.alphacognition.com/investors/news/alpha-cognition-presenting-at-the-benzinga-biotech-small-cap-conference 0.80 https://www.alphacognition.com/investors/news/alpha-cognition-announces-closing-of-qualifying-transaction 0.80 https://www.alphacognition.com/legal/ 0.80 https://www.alphacognition.com/corporate/ 0.64 https://www.alphacognition.com/treatments/alzheimers-alpha-1062/ 0.64 https://www.alphacognition.com/our-approach/ 0.64 https://www.alphacognition.com/investors/ 0.64 https://www.alphacognition.com/investors/news/crystal-bridge-provides-transaction-update 0.64 https://www.alphacognition.com/investors/news/crystal-bridge-announces-receipt-by-alpha-cognition-of-japanese-patent-for-alzheimer-drug-alpha-1062-and-announces-private-placement-updates 0.64 https://www.alphacognition.com/_resources/news/20201204.pdf 0.64 https://www.alphacognition.com/investors/news/crystal-bridge-enters-into-arrangement-agreement-with-alpha-cognition-announces-up-to-13-million-private-placement 0.64 https://www.alphacognition.com/_resources/news/20201028.pdf 0.64 https://www.alphacognition.com/investors/news/crystal-bridge-enterprises-announces-letter-of-intent-for-qualifying-transaction-with-alpha-cognition-inc 0.64 https://www.alphacognition.com/_resources/news/20200714.pdf 0.64 https://www.alphacognition.com/investors/news/alpha-cognition-inc-attends-the-bio-digital-partnering-event-this-week 0.64 https://www.alphacognition.com/_resources/news/20200608.pdf 0.64 https://www.alphacognition.com/investors/news/alpha-cognition-inc-announces-granted-eu-patents-and-orphan-drug-designation-for-its-progranulin-platform 0.64 https://www.alphacognition.com/_resources/news/20200512.pdf 0.64 https://www.alphacognition.com/investors/news/alpha-cognition-inc-receives-fdapmda-regulatory-guidance-for-alpha-1062-alzheimers-therapy 0.64 https://www.alphacognition.com/_resources/news/20200430.pdf 0.64 https://www.alphacognition.com/investors/news/linical-and-alpha-cognition-announce-strategic-partnership-to-position-alpha--1062-for-approval-in-the-unites-states-and-japan-alzheimers-markets 0.64 https://www.alphacognition.com/_resources/news/20200421.pdf 0.64 https://www.alphacognition.com/investors/news/alpha-cognition-inc-name-change 0.64 https://www.alphacognition.com/_resources/news/20200409.pdf 0.64